|
Clinical Investigator’s Warning Won’t Trip Up First HIV Home Test Launch
An investigator has been warned for failing to comply with state laws, the study protocol and IRB requirements during a clinical trial of the first FDA-approved home HIV test, OraQuick.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives